Etiology and Pathogenesis Molecular Oncology | Staging and Prognosis


Journal of Neuro-Oncology, 71(2): 85-89, January 2005. (Laboratory Investigation)


Abstract

Cellular DNA content parameters as prognostic indicators in human astrocytomas

Basil F. El-Rayes, Camille S. Norton, Wael Sakr, Zosia Maciorowski, Daryn Smith, Haline Pietraszkiewicz, Maria Del Mar Alonso and John F. Ensley

Department of Internal Medicine, Division of Hematology and Oncology, Wayne State University, Karmanos Cancer Institute, MI, USA [B.F.E.-R., C.S.N., D.S., H.P., M.D.M.A., J.F.E.]. Department of Pathology, School of Medicine, Wayne State University, Karmanos Cancer Institute, Detroit, MI, USA [W.S.]. Curie Institute, Paris, France [Z.M.]. Harper Hospital, 3990 John R, Detroit, MI 48201, USA [J.F.E.]. Correspondence to: John F. Ensley, Email: ensleyj@karmanos.org, Phone: +1-313-745-9168, Fax: +1-313-993 0559.

Objective. Clinical parameters such as grade, size and/or location of the tumor are good predictors of outcome in patients with astrocytoma. 
The objective of this study was to determine whether DNA content parameters have a prognostic significance for this group of tumors.

Methods. Following optimization and validation of methodology for evaluating cellular DNA content parameters (CDCP), tumor DNA ploidy and percent S phase fraction (SPF) were determined from 64 patients using formalin fixed, paraffin embedded specimens (mean coefficient of variation = 4.94) obtained over a 10-year period. 
Median survival times correlated with grade (I/II =1154 vs. III/IV= 483days, P=0.0317). 
Fifty-five percent of the specimens contained DNA aneuploid (DNA-A) components (average SPF=18.3%) and 45% were DNA diploid (DNA-D) (average SPF=9.6%). 
Survival did not correlate with overall differences in DNA ploidy (DNA-D=181 vs. DNA-A=206days, P=0.6314) when treated and untreated tumors were analyzed. 
However, a trend for prolonged median survival was observed in patients whose tumors were untreated with respect to cytotoxic therapy based on DNA ploidy status (DNA-D=275 vs. DNA-A=15days, P=0.3408). 
Survival for all patients did not correlate with median SPF (< 13.5% av.= 121 vs. > 13.5% av.= 154days, P=0.6534).

Conclusion. DNA content parameters may correlate with the natural history and treatment outcome of newly diagnosed untreated patients with astrocytomas.

Keywords:  aneuploid - astrocytoma - diploid

© Springer 2005

Source: http://springerlink.metapress.com/openurl.asp?genre=article&eissn=1573-7373&volume=71&issue=2&spage=85
DOI: http://dx.doi.org/10.1007/s11060-004-6044-x


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP